Skip to content

Canada to Begin Testing HIV Vaccine

Canadian researchers working to develop an HIV vaccine have received approval from the US FDA to begin human trials of the vaccine. The vaccine works by infecting cells with a virus.
Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people

What’s the Latest Development?

A team of Canadian researchers has been given approval by the US FDA to begin testing their HIV vaccine on humans. Tests will begin in January with a group of 40 HIV-positive patients to test the vaccine’s safety. Leader of the team, Dr. Chil-Yong Kang said: “The SAV001 vaccine, administered as an injection, has already gone through preliminary toxicology tests on animals. It didn’t show any adverse effects or safety concerns and can be produced in large quantities.”

What’s the Big Idea?

An HIV vaccine could be ready in five years time, say the researchers at the University of Western Ontario. Tests will begin on HIV-positive patients to determine the vaccine’s safety, then move to HIV-negative patients considered to be at high risk of contracting the virus, “including hemophiliacs, injection drug users, sex trade workers and those in the gay community with multiple sexual partners.” Trials for the first phase of study are scheduled to begin in January of next year.

Photo credit: shutterstock.com

Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people
Related
Up Next
Will Mobile Devices Kill the Credit Card?
New innovations in mobile banking are making it possible to transfer the entire payment experience from the plastic credit card to your mobile device. New upstarts with funny names that […]